AVH News: AVITA Medical Announces Topline Results from Pivotal Trial in Patients with Soft-Tissue Injuries usi - 12th Aug 2022, 6:05am

annb0t

Top 20
AVITA Medical

AVITA Medical plans to submit PMA supplement for this new indication to FDA by the end of 2022

VALENCIA, Calif. and MELBOURNE, Australia, Aug. 11, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced topline results from its pivotal randomized, controlled trial eval...

>>> Read more: AVITA Medical Announces Topline Results from Pivotal Trial in Patients with Soft-Tissue Injuries using the RECELL® System
 
Top Bottom